Company intelligence / Profile preview

Xiwang Group

Zouping County, Shandong, China

Ownership: Private
Employees: ~16000
Development stage: Commercial

Overview

Xiwang Pharmaceutical Co., Ltd, a subsidiary of Xiwang Group, is the world’s largest producer of injection-grade dextrose anhydrous and the only manufacturer of pharmaceutical maltodextrin in China. The group dominates China's medicinal glucose market with an estimated 85% share and exports to over 40 countries. Its products are widely used as pharmaceutical excipients for parenteral solutions and other medical applications.

Therapeutic areas: GastroenterologyOther
Modalities: Small molecule
Industry: Chemicals & Materials

Partnerships

Long-term supply relationships with major domestic and international food/pharma companies

Beyond the preview

Go deeper on Xiwang Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiwang Group.

Explore the full profile